Published on : Jun 29, 2016
ALBANY, New York, June 29, 2016: A market research study, titled “Point of Care Testing - Global Analysis & Market Forecasts,” has recently been added by ResearchMoz.us to its comprehensive collection of research reports. The study provides a detailed analysis of the global point of care testing market, focusing on the growth prospects, dynamics, regulatory requirements, current trends, competitive scenario, and potential opportunities for the suppliers. The past performance and estimated statistics of the global point of care testing market have been presented with the help of charts, graphs, infographics, and tables.
According to the study, the global market for point of care testing is projected to reach a value of US$38 bn by the end of 2022.
The introduction of the point of care technologies is considered as a revolutionary step in the healthcare industry. The extensive use of high-tech innovations in the healthcare industry, such as biosensors, smartphone apps, wearable devices, and lab-on-a-chip are contributing substantially towards creating a strong connection with the patient. Point-of-care tests comprise simple medical tests, which can be performed at home or any remote location and provides quick results. Furthermore, it allows in making quick decisions in physicians’ offices, patient homes, hospitals, and ambulances.
The research study provides a list of the major point of care tests such as bilirubin, urinalysis, cancer markers, blood coagulation, pregnancy and fertility, cardiac markers, lipid panel/cholesterol, HbA1C, critical care, blood glucose, drugs of abuse, clinical chemistry, and infectious disease testing. To provide a better understanding of these segments, the share and size of each segment in the global point of care testing market have been presented in the research report.
Click here to get more info with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=733705
The growing prevalence of infectious diseases in several emerging nations and the increasing number of lifestyle disorders including diabetes and cardiac diseases are the key factors propelling the growth of the global point of care testing market. In addition, the technological developments to offer easy-to-use, faster, and advanced devices and the growing use of home-based point of care devices are expected to fuel the growth of the overall market in the coming years. However, point of care testing is comparatively costlier than the lab methods, which is estimated to curb the growth of the global point of care testing market throughout the forecast period.
The global market for point of care testing is competitive in nature owing to the presence of several players operating in the market. Some of the major players in the market are Siemens AG, Beckman Coulter, Inc., Roche Diagnostics Ltd., Abbott Laboratories, Bayer AG, Johnson & Johnson, and Alere Inc.
The research report covers the market landscape and market size in the global point of care testing market. In addition, the distribution agreements, mergers and acquisitions, licensing deals, and collaboration deals are also discussed in the research report. The major drivers, barriers, and challenges in the global point of care market are evaluated in the study.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on [email protected]